bpc-157 safety human use Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing BPC-157 Explained: Benefits, Safety &

muscle aches and weakness

Indicated Cases This formulation is most appropriate for: Adult cats 2.55 kg with FIP presenting alongside anaemia (confirmed by haematology or suspected clinically) Wet FIP cases with concurrent lethargy and appetite suppression disproportionate to effusion severity Dry FIP cases with systemic involvement and immune compromise Cases where owner or veterinarian wishes to consolidate daily antiviral injection with B12 supplementation Cats on concurrent medications that may affect appetite or GI absorption This Formulation Is Not the First Choice For Cats requiring therapeutic-dose B12 at intervals other than once daily maintain a separate B12 protocol as directed by your veterinarian Cats outside the 2.55 kg weight range select the appropriate concentration for your cat's weight Cats with no secondary systemic complications the standard 30mg/ml formulation is sufficient Concentration Selection Guide Administration Administer subcutaneously once daily

I suspect the absolute risk is low for short-term use, but we do not actually know, and that uncertainty alone is a strong argument against chronic use

refer to the BNF and product SmPC for eligibility, dosing, and monitoring requirements

Clinical-Grade vs

Safety Profile & Reported Adverse Effects The Phase 2b trial (PMID: 23714218) reported a favorable short-term safety profile with no serious adverse events attributed to AOD-9604